{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:22:52Z","timestamp":1773307372817,"version":"3.50.1"},"reference-count":100,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T00:00:00Z","timestamp":1547424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Education of Singapore","award":["Tier 2 Research grant (MOE2017-T2-2-029)"],"award-info":[{"award-number":["Tier 2 Research grant (MOE2017-T2-2-029)"]}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["CIRG\/1432\/2015"],"award-info":[{"award-number":["CIRG\/1432\/2015"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Though historically known as a toxic gas, hydrogen sulfide (H2S) has displayed a new face as the third endogenous gaseous signaling molecule after nitric oxide (NO) and carbon monoxide (CO). Here in this review, we survey the role and therapeutic potential of H2S in cisplatin-induced nephrotoxicity. Specifically, reduction of H2S by cystathionine \u03b3-lyase (CSE) downregulation upon cisplatin treatment may contribute to cisplatin-induced renal cell injury, possibly by augmentation of endogenous reactive oxygen species (ROS) production, while H2S donation may prevent subsequent renal dysfunction by inhibiting NADPH oxidase activation. Intriguingly, H2S slow-releasing compound GYY4137 seems to increase the anticancer activity of cisplatin, at least in several cancer cell lines, and this is probably due to its own anticancer effect. However, the efficacy of H2S donors in tumor-bearing animals remains to be tested in terms of renal protection and cancer inhibition after receiving cisplatin. Furthermore, accumulative evidence regarding usage of polysulfide, a novel H2S derived molecule, in the therapy of cisplatin-induced nephrotoxicity, was also summarized.<\/jats:p>","DOI":"10.3390\/ijms20020313","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T12:20:07Z","timestamp":1547468407000},"page":"313","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Protective Smell of Hydrogen Sulfide and Polysulfide in Cisplatin-Induced Nephrotoxicity"],"prefix":"10.3390","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9927-6802","authenticated-orcid":false,"given":"Xu","family":"Cao","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wencan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Food Science and Technology Program, Department of Chemistry, National University of Singapore, Singapore 117600, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip K.","family":"Moore","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsong","family":"Bian","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore"},{"name":"National University of Singapore (Suzhou) Research Institute, Suzhou 215123, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,1,14]]},"reference":[{"key":"ref_1","first-page":"93","article-title":"Hydrogen sulfide poisoning","volume":"21","author":"Smith","year":"1979","journal-title":"J. Occup. Med. Off. Publ. Ind. Med. Assoc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1523\/JNEUROSCI.16-03-01066.1996","article-title":"The possible role of hydrogen sulfide as an endogenous neuromodulator","volume":"16","author":"Abe","year":"1996","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1681\/ASN.2012030268","article-title":"Cystathionine gamma-lyase protects against renal ischemia\/reperfusion by modulating oxidative stress","volume":"24","author":"Bos","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1096\/fj.02-0211hyp","article-title":"Two\u2019s company, three\u2019sa crowd: Can H2S be the third endogenous gaseous transmitter?","volume":"16","author":"Wang","year":"2002","journal-title":"FASEB J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/nau.22450","article-title":"Exogenous hydrogen sulfide prevents kidney damage following unilateral ureteral obstruction","volume":"33","author":"Jiang","year":"2014","journal-title":"Neurourol. Urodyn."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"F27","DOI":"10.1152\/ajprenal.00096.2009","article-title":"Ischemia-reperfusion reduces cystathionine-beta-synthase-mediated hydrogen sulfide generation in the kidney","volume":"297","author":"Xu","year":"2009","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_7","first-page":"121","article-title":"Hydrogen sulfide ameliorates the kidney dysfunction and damage in cisplatin-induced nephrotoxicity in rat","volume":"5","author":"Ahangarpour","year":"2014","journal-title":"Vet. Res. Forum Int. Q. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"150","DOI":"10.15171\/jnp.2017.26","article-title":"Sodium hydrogen sulfide (NaHS) ameliorates alterations caused by cisplatin in filtration slit diaphragm and podocyte cytoskeletal in rat kidney","volume":"6","author":"Karimi","year":"2017","journal-title":"J. Nephropathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fphar.2016.00385","article-title":"The Role of Hydrogen Sulfide in Renal System","volume":"7","author":"Cao","year":"2016","journal-title":"Front. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.pharep.2017.10.007","article-title":"The smell of renal protection against chronic kidney disease: Hydrogen sulfide offers a potential stinky remedy","volume":"70","author":"Dugbartey","year":"2018","journal-title":"Pharmacol. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bcp.2017.12.005","article-title":"Hydrogen sulfide as a regulatory factor in kidney health and disease","volume":"149","author":"Kasinath","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1021\/tx100266a","article-title":"Rapid reaction of hydrogen sulfide with the neutrophil oxidant hypochlorous acid to generate polysulfides","volume":"23","author":"Nagy","year":"2010","journal-title":"Chem. Res. Toxicol."},{"key":"ref_13","first-page":"2451","article-title":"Polysulfides are possible H2S-derived signaling molecules in rat brain","volume":"27","author":"Kimura","year":"2013","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6904327","DOI":"10.1155\/2016\/6904327","article-title":"Interaction of Hydrogen Sulfide with Nitric Oxide in the Cardiovascular System","volume":"2016","author":"Nagpure","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"14774","DOI":"10.1038\/srep14774","article-title":"Identification of H2S3 and H2S produced by 3-mercaptopyruvate sulfurtransferase in the brain","volume":"5","author":"Kimura","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"20002","DOI":"10.1074\/jbc.M113.466177","article-title":"Structure and kinetic analysis of H2S production by human mercaptopyruvate sulfurtransferase","volume":"288","author":"Yadav","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: Molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/cancers3011351","article-title":"Cisplatin as an anti-tumor drug: Cellular mechanisms of activity, drug resistance and induced side effects","volume":"3","author":"Florea","year":"2011","journal-title":"Cancers"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0272-6386(86)80112-3","article-title":"Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity","volume":"8","author":"Ries","year":"1986","journal-title":"Am. J. Kidney Dis."},{"key":"ref_20","first-page":"173","article-title":"Organo-platinum complexes as antitumor agents (review)","volume":"2","author":"Hill","year":"1981","journal-title":"Anticancer Res."},{"key":"ref_21","first-page":"1","article-title":"Acute toxicologic and pathologic effects of cis-diamminedichloroplatinum (NSC-119875) in the male rat","volume":"55","author":"Kociba","year":"1971","journal-title":"Cancer Chemother. Rep. Part 1"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of cisplatin nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00280-003-0620-1","article-title":"Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: A randomized trial","volume":"52","author":"Santoso","year":"2003","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000086055","article-title":"Cisplatin-associated nephrotoxicity and pathological events","volume":"Volume 148","author":"Taguchi","year":"2005","journal-title":"Cellular Stress Responses in Renal Diseases"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1200\/JCO.1987.5.2.304","article-title":"Creatinine clearance as a predictor of ultrafilterable platinum disposition in cancer patients treated with cisplatin: Relationship between peak ultrafilterable platinum plasma levels and nephrotoxicity","volume":"5","author":"Reece","year":"1987","journal-title":"J. Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0002-9343(78)90825-2","article-title":"Platinum nephrotoxicity","volume":"65","author":"Madias","year":"1978","journal-title":"Am. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1200\/JCO.2001.19.17.3733","article-title":"Body-surface area\u2013based dosing does not increase accuracy of predicting cisplatin exposure","volume":"19","author":"Verweij","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/sj.bjc.6600884","article-title":"Weekly high-dose cisplatin is a feasible treatment option: Analysis on prognostic factors for toxicity in 400 patients","volume":"88","author":"Veltman","year":"2003","journal-title":"Br. J. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/0272-0590(89)90026-2","article-title":"Attenuation of cisplatin nephrotoxicity by streptozotocin-induced diabetes","volume":"12","author":"Scott","year":"1989","journal-title":"Fundam. Appl. Toxicol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/gyno.1996.0090","article-title":"The impact of diabetes mellitus on the toxicity of therapy for advanced ovarian cancer","volume":"61","author":"Gogas","year":"1996","journal-title":"Gynecol. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s002800050661","article-title":"Association of cisplatin nephrotoxicity with patient characteristics and cisplatin administration methods","volume":"40","author":"Stewart","year":"1997","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/clpt.2009.139","article-title":"Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced Nephrotoxicity","volume":"86","author":"Filipski","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2353\/ajpath.2010.090610","article-title":"Organic cation transporter 2 mediates cisplatin-induced oto-and nephrotoxicity and is a target for protective interventions","volume":"176","author":"Ciarimboli","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MAJ.0b013e31812dfe1e","article-title":"Cisplatin nephrotoxicity: A review","volume":"334","author":"Yao","year":"2007","journal-title":"Am. J. Med. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ki.1984.86","article-title":"Uptake and metabolism of cisplatin by rat kidney","volume":"25","author":"Safirstein","year":"1984","journal-title":"Kidney Int."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00280-002-0537-0","article-title":"Inhibition of basolateral transport and cellular accumulation of cDDP and N-acetyl-l-cysteine-cDDP by TEA and PAH in the renal proximal tubule","volume":"51","author":"Kolb","year":"2003","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"14298","DOI":"10.1073\/pnas.162491399","article-title":"Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals","volume":"99","author":"Ishida","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"F505","DOI":"10.1152\/ajprenal.90545.2008","article-title":"The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity","volume":"296","author":"Pabla","year":"2009","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1523-1755.2004.00720.x","article-title":"Nephrotoxicity of platinum complexes is related to basolateral organic cation transport","volume":"66","author":"Ludwig","year":"2004","journal-title":"Kidney Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S0002-9440(10)61234-5","article-title":"Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2","volume":"167","author":"Ciarimboli","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"F610","DOI":"10.1152\/ajprenal.00101.2003","article-title":"TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. American journal of physiology","volume":"285","author":"Ramesh","year":"2003","journal-title":"Ren. Physiol."},{"key":"ref_42","first-page":"F700","article-title":"Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: Apoptosis vs. necrosis","volume":"270","author":"Lieberthal","year":"1996","journal-title":"Am. J. Physiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.ki.5002256","article-title":"The pathological role of Bax in cisplatin nephrotoxicity","volume":"72","author":"Wei","year":"2007","journal-title":"Kidney Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1081\/DMR-100101947","article-title":"Oxidant mechanisms in toxic acute renal failure","volume":"31","author":"Baliga","year":"1999","journal-title":"Drug Metab. Rev."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Arany, I., and Safirstein, R.L. (2003). Cisplatin Nephrotoxicity, Seminars in Nephrology, Elsevier.","DOI":"10.1016\/S0270-9295(03)00089-5"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1172\/JCI45586","article-title":"Inhibition of PKC\u03b4 reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer","volume":"121","author":"Pabla","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_47","first-page":"638","article-title":"Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: Mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain","volume":"280","author":"Kruidering","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.biopha.2011.07.001","article-title":"Oxytocin inhibits NADPH oxidase and P38 MAPK in cisplatin-induced nephrotoxicity","volume":"65","author":"Rashed","year":"2011","journal-title":"Biomed. Pharmacother."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jbt.21679","article-title":"Superoxide anion production and expression of gp91(phox) and p47(phox) are increased in glomeruli and proximal tubules of cisplatin-treated rats","volume":"29","author":"Trujillo","year":"2015","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.fct.2015.05.007","article-title":"Pharmacological inhibition of NADPH oxidase protects against cisplatin induced nephrotoxicity in mice by two step mechanism","volume":"83","author":"Wang","year":"2015","journal-title":"Food Chem. Toxicol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1046\/j.1523-1755.2003.00908.x","article-title":"Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis","volume":"63","author":"Liu","year":"2003","journal-title":"Kidney Int."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1038\/sj.onc.1210412","article-title":"Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases","volume":"26","author":"Owens","year":"2007","journal-title":"Oncogene"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"43377","DOI":"10.1074\/jbc.M206373200","article-title":"Protein kinase C-alpha and ERK1\/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells","volume":"277","author":"Nowak","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"F543","DOI":"10.1152\/ajprenal.00112.2004","article-title":"Cisplatin-induced cell death is EGFR\/src\/ERK signaling dependent in mouse proximal tubule cells. American journal of physiology","volume":"287","author":"Arany","year":"2004","journal-title":"Ren. Physiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/jat.1081","article-title":"Role of ERK activation in cisplatin-induced apoptosis in OK renal epithelial cells","volume":"25","author":"Kim","year":"2005","journal-title":"J. Appl. Toxicol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.freeradbiomed.2005.12.025","article-title":"Protective effect of cyclic AMP against cisplatin-induced nephrotoxicity","volume":"40","author":"Mishima","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"F166","DOI":"10.1152\/ajprenal.00401.2004","article-title":"p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. American journal of physiology","volume":"289","author":"Ramesh","year":"2005","journal-title":"Ren. Physiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1097\/01.ASN.0000079785.13922.F6","article-title":"Recent advances in the pathophysiology of ischemic acute renal failure","volume":"14","author":"Bonventre","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1523-1755.2004.00413.x","article-title":"Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-alpha","volume":"65","author":"Ramesh","year":"2004","journal-title":"Kidney Int."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1172\/JCI200215606","article-title":"TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity","volume":"110","author":"Ramesh","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/08860220600843839","article-title":"Cisplatin increases TNF-alpha mRNA stability in kidney proximal tubule cells","volume":"28","author":"Ramesh","year":"2006","journal-title":"Ren. Fail."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/sj.ki.5002242","article-title":"Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells","volume":"72","author":"Zhang","year":"2007","journal-title":"Kidney Int."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1124\/jpet.107.119792","article-title":"Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney","volume":"322","author":"Faubel","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/gyno.1993.1184","article-title":"Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin","volume":"50","author":"Cornelison","year":"1993","journal-title":"Gynecol. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/0360-3016(79)90677-1","article-title":"The effect of diuretic pre-treatment on clinical, morphological and ultrastructural cis-platinum induced nephrotoxicity","volume":"5","author":"Lehane","year":"1979","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00280-008-0711-0","article-title":"Prevention of cisplatin nephrotoxicity: State of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care","volume":"61","author":"Rey","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1200\/JCO.2006.06.0913","article-title":"Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: An intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG","volume":"24","author":"Pfisterer","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1008215213739","article-title":"Carboplatin versus cisplatin in solid tumors: An analysis of the literature","volume":"9","author":"Lokich","year":"1998","journal-title":"Ann. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/ndt\/gfr560","article-title":"Downregulation of the renal and hepatic hydrogen sulfide (H2S)-producing enzymes and capacity in chronic kidney disease","volume":"27","author":"Aminzadeh","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"21972","DOI":"10.1073\/pnas.0908047106","article-title":"Hydrogen sulfide is an endogenous stimulator of angiogenesis","volume":"106","author":"Papapetropoulos","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"8145785","DOI":"10.1155\/2016\/8145785","article-title":"A H 2 S Donor GYY4137 Exacerbates Cisplatin-Induced Nephrotoxicity in Mice","volume":"2016","author":"Liu","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/ars.2017.7157","article-title":"Renal Protective Effect of Hydrogen Sulfide in Cisplatin-Induced Nephrotoxicity","volume":"29","author":"Cao","year":"2018","journal-title":"Antioxid. Redox Signal."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1039\/9781788013000-00145","article-title":"The Signaling Interaction Systems of in NO Biology and H2S and Medicine","volume":"12","author":"Cao","year":"2018","journal-title":"Gasotransmitters"},{"key":"ref_75","first-page":"3789","article-title":"A New Hope for a Devastating Disease: Hydrogen Sulfide in Parkinson\u2019s Disease","volume":"55","author":"Cao","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bcp.2017.11.011","article-title":"The role of hydrogen sulfide in cyclic nucleotide signaling","volume":"149","author":"Cao","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.phrs.2016.08.007","article-title":"HNO suppresses LPS-induced inflammation in BV-2 microglial cells via inhibition of NF-kappaB and p38 MAPK pathways","volume":"111","author":"Zhou","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Whiteman, M., Perry, A., Zhou, Z., Bucci, M., Papapetropoulos, A., Cirino, G., and Wood, M.E. (2015). Phosphinodithioate and phosphoramidodithioate hydrogen sulfide donors. Chemistry, Biochemistry and Pharmacology of Hydrogen Sulfide, Springer.","DOI":"10.1007\/978-3-319-18144-8_17"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1161\/CIRCULATIONAHA.107.753467","article-title":"Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): New insights into the biology of hydrogen sulfide","volume":"117","author":"Li","year":"2008","journal-title":"Circulation"},{"key":"ref_80","first-page":"493","article-title":"Effect of synthesized GYY4137, a slowly releasing hydrogen sulfide donor, on cell viability and distribution of hydrogen sulfide in mice","volume":"42","author":"Yu","year":"2010","journal-title":"Health Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"203","DOI":"10.7555\/JBR.28.20140037","article-title":"GYY4137 protects against myocardial ischemia and reperfusion injury by attenuating oxidative stress and apoptosis in rats","volume":"29","author":"Meng","year":"2015","journal-title":"J. Biomed. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"691070","DOI":"10.1155\/2015\/691070","article-title":"Hydrogen Sulfide Donor GYY4137 Protects against Myocardial Fibrosis","volume":"2015","author":"Meng","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.juro.2016.05.029","article-title":"GYY4137, a slow-releasing hydrogen sulfide donor, ameliorates renal damage associated with chronic obstructive uropathy","volume":"196","author":"Lin","year":"2016","journal-title":"J. Urol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.niox.2015.05.001","article-title":"Mitochondria-targeted hydrogen sulfide donor AP39 improves neurological outcomes after cardiac arrest in mice","volume":"49","author":"Ikeda","year":"2015","journal-title":"Nitric Oxide Biol. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/bph.13688","article-title":"AP39, a mitochondria-targeting hydrogen sulfide (H2 S) donor, protects against myocardial reperfusion injury independently of salvage kinase signalling","volume":"174","author":"Karwi","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ajpath.2011.11.001","article-title":"Autophagy guards against cisplatin-induced acute kidney injury","volume":"180","author":"Takahashi","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.freeradbiomed.2013.02.025","article-title":"Nitroxyl (HNO) suppresses vascular Nox2 oxidase activity","volume":"60","author":"Miller","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cardiores.2007.03.030","article-title":"Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells","volume":"75","author":"Selemidis","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1016\/j.febslet.2013.09.013","article-title":"Polysulfide exerts a protective effect against cytotoxicity caused by t-buthylhydroperoxide through Nrf2 signaling in neuroblastoma cells","volume":"587","author":"Koike","year":"2013","journal-title":"FEBS Lett."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.freeradbiomed.2017.01.026","article-title":"Hydrogen sulfide reduces RAGE toxicity through inhibition of its dimer formation","volume":"104","author":"Zhou","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1590\/S0100-879X2012007500090","article-title":"Hydrogen sulfide postconditioning protects isolated rat hearts against ischemia and reperfusion injury mediated by the JAK2\/STAT3 survival pathway","volume":"45","author":"Luan","year":"2012","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.niox.2016.04.005","article-title":"Hydrogen sulfide: A novel nephroprotectant against cisplatin-induced renal toxicity","volume":"57","author":"Dugbartey","year":"2016","journal-title":"Nitric Oxide"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Cao, X., Ding, L., Xie, Z.Z., Yang, Y., Whiteman, M., Moore, P.K., and Bian, J.S. (2018). A Review of Hydrogen Sulfide Synthesis, Metabolism, and Measurement: Is Modulation of Hydrogen Sulfide a Novel Therapeutic for Cancer?. Antioxid. Redox Signal.","DOI":"10.1089\/ars.2017.7058"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1089\/ars.2013.5308","article-title":"Anti-cancer activity of new designer hydrogen sulfide-donating hybrids","volume":"20","author":"Kashfi","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Lee, Z.W., Zhou, J., Chen, C.S., Zhao, Y., Tan, C.H., Li, L., Moore, P.K., and Deng, L.W. (2011). The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0021077"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.redox.2018.01.012","article-title":"Renal protective effect of polysulfide in cisplatin-induced nephrotoxicity","volume":"15","author":"Cao","year":"2018","journal-title":"Redox Biol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.neuint.2013.09.003","article-title":"Physiological role of hydrogen sulfide and polysulfide in the central nervous system","volume":"63","author":"Kimura","year":"2013","journal-title":"Neurochem. Int."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/ars.2017.7076","article-title":"Hydrogen Sulfide and Polysulfide Signaling","volume":"27","author":"Kimura","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/ars.2010.3110","article-title":"Transtympanic administration of short interfering (si) RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat","volume":"13","author":"Mukherjea","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1523\/JNEUROSCI.6054-09.2010","article-title":"Roles of NADPH oxidases in cisplatin-induced reactive oxygen species generation and ototoxicity","volume":"30","author":"Kim","year":"2010","journal-title":"J. Neurosci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/2\/313\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:25:48Z","timestamp":1760185548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/2\/313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,14]]},"references-count":100,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,1]]}},"alternative-id":["ijms20020313"],"URL":"https:\/\/doi.org\/10.3390\/ijms20020313","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,14]]}}}